Curative Biotechnology Announces Canadian Patent Allowance
Curative Biotechnology Announces Canadian Patent Allowance GlobeNewswire January 23, 2026 “Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the “Company”), a company developing metformin-based eye drops for the treatment of degenerative eye diseases, today announced that the Canadian Intellectual Property […]